The city of Huntington Beach, California, currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Recruiting
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).
Gender:
All
Ages:
Between 65 years and 80 years
Trial Updated:
06/17/2024
Locations: Care Access Research - Huntington Beach, Huntington Beach, California
Conditions: Alzheimer Disease